Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer

Carcinogenesis

Volumn 31, Issue 8, 2010, Pages 1381-1386

  Frank, Bernd ^a   Hoffmeister, Michael ^a   Klopp, Norman ^b   Illig, Thomas ^b   Chang Claude, Jenny ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

WNT PROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CELL DEATH; COLORECTAL CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; APOPTOSIS; CARRIER STATE; CASE-CONTROL STUDIES; CELL DEATH; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GERMANY; HOMOZYGOTE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RISK FACTORS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 77955356519     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq082     Document Type: Article

References (51)

1. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. Ferlay,J. et al. (2004) GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0. IARCPress, Lyon.
3. Pisani,P. et al. (2002) Estimates of the worldwide prevalence of cancer for 25 cancers in the adult population. Int. J. Cancer, 97, 72-81.
4. Potter,J.D. (1999) Colorectal cancer: molecules and populations. J. Natl Cancer Inst., 91, 916-932.
5. Lichtenstein,P. et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
6. de la Chapelle,A. (2004) Genetic predisposition to colorectal cancer. Nat. Rev. Cancer, 4, 769-780.
7. Klaus,A. et al. (2008) Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer, 8, 387-398.
8. Fodde,R. et al. (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer, 1, 55-67.
9. Bienz,M. et al. (2000) Linking colorectal cancer to Wnt signaling. Cell, 103, 311-320.
10. Kinzler,K.W. et al. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
11. Huang,H. et al. (2008) Wnt/beta-catenin signaling: new (and old) players and new insights. Curr. Opin. Cell Biol., 20, 119-125.
12. Katoh,M. (2001) Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. Int. J. Oncol., 19, 1003-1007.
13. Huang,D. et al. (2010) SFRP4 was overexpressed in colorectal carcinoma. J. Cancer Res. Clin. Oncol., 136, 395-401.
14. Bovolenta,P. et al. (2008) Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J. Cell Sci., 121, 737-746.
15. Suzuki,H. et al. (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet., 36, 417-422.
16. Suzuki,H. et al. (2003) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet., 31, 141-149.
17. Shi,Y. et al. (2007) Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells. Int. J. Cancer, 121, 1175-1181.
18. Olmeda,D. et al. (2003) Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis. Mol. Biol. Cell, 14, 2844-2860.
19. West,N.J. et al. (2009) Apoptosis in the colonic crypt, colorectal adenomata, and manipulation by chemoprevention. Cancer Epidemiol. Biomarkers Prev., 18, 1680-1687.
20. Watson,A.J. (1995) Review article: manipulation of cell death-the development of novel strategies for the treatment of gastrointestinal disease. Aliment. Pharmacol. Ther., 9, 215-226.
21. Masuda,Y. et al. (2006) The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage. J. Hum. Genet., 51, 652-664.
22. Wincewicz,A. et al. (2007) Cumulative expression of HIF-1-alpha, Bax, Bcl-xL and P53 in human colorectal cancer. Pathology, 39, 334-338.
23. Greijer,A.E. et al. (2004) The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol., 57, 1009-1014.
24. Stein,S. et al. (2004) NDRG1 is necessary for p53-dependent apoptosis. J. Biol. Chem., 279, 48930-48940.
25. Andrews,P.G. et al. (2009) The transcriptional activity of Pygopus is enhanced by its interaction with cAMP-response-element-binding protein (CREB)-binding protein. Biochem. J., 422, 493-501.
26. Kramps,T. et al. (2002) Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell, 109, 47-60.
27. Xu,L. et al. (2000) WISP-1 is a Wnt-1-and beta-catenin-responsive oncogene. Genes Dev., 14, 585-595.
28. Pennica,D. et al. (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl Acad. Sci. USA, 95, 14717-14722.
29. Thorstensen,L. et al. (2001) WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology, 121, 1275-1280.
30. Ramensky,V. et al. (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res., 30, 3894-3900.
31. Kumar,P. et al. (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc., 4, 1073-1081.
32. Brenner,H. et al. (2006) Does a negative screening colonoscopy ever need to be repeated? Gut, 55, 1145-1150.
33. Lilla,C. et al. (2006) Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol. Biomarkers Prev., 15, 99-107.
34. Frank,B. et al. (2010) Colorectal Cancer and Polymorphisms in DNA Repair Genes WRN, RMI1, and BLM. Carcinogenesis, 31, 442-445.
35. Kim,M.S. et al. (2008) Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene, 27, 3624-3634.
36. Zhong,H. et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res., 59, 5830-5835.
37. Strzelczyk,B. et al. (2009) Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Ann. Surg. Oncol., 16, 1287-1294.
38. Khor,T.O. et al. (2006) A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int. J. Colorectal Dis., 21, 291-300.
39. Akino,K. et al. (2007) Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer. Cancer Sci., 98, 88-95.
40. Lee,J.Y. et al. (2008) Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women. Clin. Chim. Acta, 389, 167-170.
41. Lopez,R. et al. (2003) WU-Blast2 server at the European Bioinformatics Institute. Nucleic Acids Res., 31, 3795-3798.
42. Krek,A. et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495-500.
43. Gabriel,S.B. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
44. Kormann,M.S. et al. (2005) G-Protein-coupled receptor polymorphisms are associated with asthma in a large German population. Am. J. Respir. Crit. Care Med., 171, 1358-1362.
45. Dupont,W.D. et al. (1998) Power and sample size calculations for studies involving linear regression. Control. Clin. Trials, 19, 589-601.
46. Wang,G.L. et al. (1995) Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem., 270, 1230-1237.
47. Hammond,E.M. et al. (2005) The role of p53 in hypoxia-induced apoptosis. Biochem. Biophys. Res. Commun., 331, 718-725.
48. Rasheed,S. et al. (2009) Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis. Br. J. Cancer, 100, 1666-1673.
49. Lu,X.G. et al. (2006) Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. Clin. Colorectal Cancer, 5, 350-353.
50. Tanimoto,K. et al. (2003) Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis, 24, 1779-1783.
51. Fransén,K. et al. (2006) Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol. Carcinog., 45, 833-840.